Business Model & Strategy. Developing innovative small molecule drugs to treat eye diseases with high unmet medical need. PANOPTES PHARMA GES.M.B.H, REISNERSTRASSE 34/1, 1030 WIEN, AUSTRIA. INFO@PANOPTES-PHARMA.COM. Business Model & Strategy.
http://www.panoptes-pharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
0.8 seconds
16x16
Franz Obermayr
Hyeg●●●●4/10
W●n , 1030
AT
View this contact
Franz Obermayr
Hyeg●●●●4/10
W●n , 1030
AT
View this contact
1&1 Internet AG
Hostmaster EINSUNDEINS
Brau●●●●. 48
Kar●●●uhe , 76135
DE
View this contact
BUY YOUR DOMAIN
11
YEARS
6
MONTHS
4
DAYS
1 & 1 INTERNET AG
WHOIS : whois.schlund.info
REFERRED : http://1and1.com
PAGES IN
THIS WEBSITE
13
SSL
EXTERNAL LINKS
0
SITE IP
217.160.122.87
LOAD TIME
0.766 sec
SCORE
6.2
Panoptes | panoptes-pharma.com Reviews
https://panoptes-pharma.com
Business Model & Strategy. Developing innovative small molecule drugs to treat eye diseases with high unmet medical need. PANOPTES PHARMA GES.M.B.H, REISNERSTRASSE 34/1, 1030 WIEN, AUSTRIA. INFO@PANOPTES-PHARMA.COM. Business Model & Strategy.
panoptes-pharma.com
About Us | Panoptes
http://www.panoptes-pharma.com/company/about-us
Business Model & Strategy. Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria. Panoptes’ aim is to generate future growth by achieving major development milestones and by entering into partnerships with leading pharmaceutical companies. We believe the combination of our technology and cost-efficient development strategy will he...
Viral Conjunctivitis | Panoptes
http://www.panoptes-pharma.com/pipeline/therapeutic_areas/viral-conjunctivitis
Business Model & Strategy. Conjunctivitis (often called pink eye ) is an inflammation of the conjunctiva, which is the mucous membrane covering the white part of the eye and the inner side of the eyelid. Symptoms of EKC include acute onset of watering redness, foreign body sensation and severe pain, diminished eyesight, tearing, and sensitivity to light. In approximately 20-50% of patients, an immune T cell mediated infiltration of the corneal stroma that results in deteriorating vision is observed.
Business Model & Strategy | Panoptes
http://www.panoptes-pharma.com/company/business-model-strategy
Business Model & Strategy. Business Model & Strategy. Panoptes intends to develop PP-001 up to proof-of-concept studies in humans. For posterior uveitis, a sub-population of uveitis, orphan drug status will be applied which will allow accelerated approvals, financial incentives, higher reimbursement rates and prolonged market exclusivity. PANOPTES PHARMA GES.M.B.H, REISNERSTRASSE 34/1, 1030 WIEN, AUSTRIA. INFO@PANOPTES-PHARMA.COM. Business Model & Strategy.
Uveitis | Panoptes
http://www.panoptes-pharma.com/pipeline/therapeutic_areas/uveitis
Business Model & Strategy. Key facts about Uveitis. Uveitis is one of the leading causes of blindness in the world and the fourth leading cause in the western world. Several million patients suffer from any form of uveitis. Posterior non-infectious uveitis is a registered orphan indication. Uveitis can occur in any age group. Current treatment involves corticosteroids (Prednisolon or Dexamethason) and severe immunosuppressive drugs (Cyclosporine). Business Model & Strategy.
Company | Panoptes
http://www.panoptes-pharma.com/company
Business Model & Strategy. Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria. More information. We were inspired by Argus Panoptes, a giant in Greek mythology who possessed a hundred eyes. More information. Business Model and Strategy. Business Model & Strategy.
TOTAL PAGES IN THIS WEBSITE
13
Teknisult Enterprises Ltd (c)2014
Teknisult Name and Logo are Registered Trademarks of Teknisult Enterprises Ltd. All information on this website is protected and subject to change.
Panoptes
Panoptes is a private investigation and risk management company that specialises in surveillance, counter-eavesdropping and protective services. Panoptes has access to a national network of former Police Detectives and Royal Marines who have a wealth of experience in identifying, assessing and mitigating safety risks. We provide services for both corporate and private clients who trust us to understand their needs and offer bespoke and discreet security solutions.
Panoptes - Cabinet de conseil en organisation - Paris (75001) - Panoptes
Regarder - Imaginer - Oser. Le Fondateur et les Directeurs. Offres - Veille Enquêtes. Bienvenue sur le site de Panoptes. Conseil en organisation, management et stratégie. Panoptes regroupe un ensemble de consultants séniors expérimentés ayant exercé des responsabilités de management dans des Groupes français et internationaux. Panoptes aide les Entrepreneurs et les Managers à :. Leur activité différemment,. Des ruptures dans l’offre et dans la manière de la délivrer,. Agrave; optimiser leur straté...
Panoptes
Business Model & Strategy. Developing innovative small molecule drugs to treat eye diseases with high unmet medical need. PANOPTES PHARMA GES.M.B.H, REISNERSTRASSE 34/1, 1030 WIEN, AUSTRIA. INFO@PANOPTES-PHARMA.COM. Business Model & Strategy.
Panoptes | Protecting Life and Assets
Home
panoptes - Lektorat und Redaktion: Home
Referent für Presse- und Öffentlichkeitsarbeit. Zu meinen Arbeitsfeldern zählen:. Stadt- und Standortmarketing Umweltkommunikation Öffentlicher Sektor Fundraising. Politik Bildung Ökotrophologie Wirtschaft Sozialwissenschaftliche Umweltforschung. SF Fantasy Historische Szenarien.
PANOPTES - smart aerial drone inspection technology
And spatially enabled software for. What is lacking in the traditional aerial inspections by UAVs? April 23, 2015. MT-Panoptes a SolarExpo: ispezioni termografiche da drone con cuore GEO. March 29, 2015. MT-Panoptes al Solarexpo-The Innovation Cloud. March 23, 2015. Panoptes Srl sarà presente per la prima volta a Solarexpo-The Innovation Cloud per presentare, a potenziali clienti nazionali ed esteri, mT-Panoptes un sistema multi-sensore plug&play per ispezioni termografiche preventive di campi fotovoltai...
